Insulet
PODD
#1076
Rank
S$26.68 B
Marketcap
S$379.11
Share price
1.49%
Change (1 day)
6.68%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2025 (TTM): S$0.47 Billion

According to Insulet's latest financial reports the company's current earnings are S$2.52 Billion. In 2024 the company made an earning of S$0.44 Billion, an increase over its 2023 earnings that were of S$0.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.47 B8.4%
2024 S$0.44 B36.76%
2023 S$0.32 B481.9%
2022 S$55.59 M-45.24%
2021 S$0.10 B43.35%
2020 S$70.81 M18.51%
2019 S$59.75 M41.16%
2018 S$42.33 M-711.95%
2017 -S$6.92 Million-56.85%
2016 -S$16.04 Million-79.31%
2015 -S$77.51 Million63.85%
2014 -S$47.31 Million31.04%
2013 -S$36.1 Million-21.96%
2012 -S$46.26 Million
2010 -S$44.12 Million-42.38%
2009 -S$76.58 Million-33.56%
2008 -S$0.12 Billion65.93%
2007 -S$69.46 Million209.75%
2006 -S$22.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ICU Medical
ICUI
S$0.16 B-65.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-S$0.27 Billion-156.35%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
S$1.26 B 168.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$41.78 B 8,807.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.49 B 2,137.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
S$8.26 B 1,662.44%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
S$29.02 B 6,087.41%๐Ÿ‡บ๐Ÿ‡ธ USA